A lab technician visually inspects a filled vial of investigational coronavirus disease (COVID-19) treatment drug remdesivir at a Gilead Sciences facility in La Verne, California, March 11, 2020. Gilead Sciences | via REUTERS Gilead Sciences has struck a licensing agreement with five generic drugmakers to make antiviral drug remdesivir in […]